This inventor holds 1 USPTO granted patent. Top assignee: Je Il Pharmaceutical Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Young-II Moon: Innovator in Neural Progenitor Generation
Introduction
Young-II Moon is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of stem cell research, particularly in the generation of neural progenitors and neurons. His innovative methods have the potential to impact treatments for various neurological diseases.
Latest Patents
Young-II Moon holds a patent for the invention titled "Efficient generation of neural progenitors, neurons, and dopaminergic neurons from human embryonic stem cells." This invention relates to a method for inducing the differentiation of neural progenitors, neurons, and dopaminergic neurons from human embryonic stem cells with high efficiency. The method allows for neural selection through selected media and physical methods. The advantages of this invention include higher efficiency, reduced costs and time, and the ability to maintain neural progenitors for extended periods. This method can stably generate cells that are useful for treating Parkinson's disease and other nervous system disorders. He has 1 patent to his name.
Career Highlights
Young-II Moon is currently associated with Je Il Pharmaceutical Co., Ltd., where he continues to advance his research and innovations. His work is recognized for its potential to revolutionize treatments in the field of neurology.
Collaborations
Some of his notable coworkers include Shin Yong Moon and Sun Kyung Oh, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Young-II Moon's innovative work in the field of neural progenitor generation showcases his commitment to advancing medical science. His contributions have the potential to significantly improve treatment options for neurological diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile